International Flavors & Fragrances
Creates flavors, fragrances, enzymes, cultures, probiotics, and specialty bioscience ingredients for manufacturers.
Something off on this page? Send us feedback.
Profile
Creates flavors and fragrances plus enzymes, cultures, probiotics, and specialty bioscience ingredients for manufacturers, pairing proprietary formulations with customer application work. Continuing operations center on Taste, Scent, and Health & Biosciences, while Food Ingredients is classified as discontinued operations under an agreed sale.
Develops flavor compounds, natural taste solutions, fragrances, enzymes, cultures, probiotics, and other biotechnology-derived inputs used by food, beverage, home-care, personal-care, wellness, and industrial manufacturers. Continuing operations are organized as Taste, Scent, and Health & Biosciences: Taste builds flavor systems; Scent creates fine and consumer fragrances plus fragrance ingredients; Health & Biosciences supplies enzymes, cultures, probiotics, and specialty ingredients for food and non-food applications.
Combines consumer research, proprietary formulations, biotechnology, and application laboratories to adapt ingredients to customers' products across global markets. Production depends on a wide range of natural and synthetic raw materials and compliance with food, personal-care, animal-feed, and environmental rules. Food Ingredients is reported as discontinued operations under an agreed sale whose closing remains subject to regulatory approvals.
Company facts
Categories
Key statistics
Year to date +29.3% · Average volume (30d) 1.6M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 7, 2026 | Barclays | Reiterate | Overweight | $90 | $96 |
| Aug 6, 2026 | Robert W. Baird | Target | $90 | $100 | |
| Aug 6, 2026 | UBS | Reiterate | Neutral | $75 | $91 |
| Aug 6, 2026 | Oppenheimer | Reiterate | Outperform | $90 | $95 |
| Aug 6, 2026 | Vertical Research | Downgrade | Hold | $93 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | $1.07 | $0.82 | −23.4% | $2.62B | $1.95B | −25.4% | +8.88% |
| May 5, 2026Q1 FY26 | $1.08 | $1.25 | +15.7% | $2.64B | $2.74B | +3.7% | +17.18% |
| Feb 11, 2026Q4 FY25 | $0.83 | $0.80 | −3.4% | $2.51B | $2.59B | +3.0% | +5.89% |
| Nov 4, 2025Q3 FY25 | $1.02 | $1.05 | +2.9% | $2.63B | $2.69B | +2.3% | +4.08% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.84B | $2.76B | $2.69B | $2.59B | $2.74B | $1.95B | |
| Gross profit | $1.04B | $1.03B | $983.0M | $890.0M | $1.02B | $853.0M | |
| Operating income | −$903.0M | $198.0M | $226.0M | $113.0M | $279.0M | $158.0M | |
| Net income | −$1.02B | $612.0M | $40.0M | $31.0M | $169.0M | $50.0M | |
| Diluted EPS | −$3.98 | $2.38 | $0.16 | $0.07 | $0.66 | $0.19 | |
| Gross margin | 36.4% | 37.3% | 36.5% | 34.4% | 37.1% | 43.7% | |
| Operating margin | -31.8% | 7.2% | 8.4% | 4.4% | 10.2% | 8.1% |
Fiscal years (4-quarter sums)FY21 $11.66B · FY22 $12.44B · FY23 $11.48B · FY24 $11.48B · FY25 $10.89B
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $569.0M · Total debt $6.24B · Total assets $25.15B · Shareholders' equity $13.98B
Dividends
Last cut to $0.40 from $0.81 in Mar 2024. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 18, 2026 | Jun 18 | Jul 10 | $0.40 | |
| Mar 20, 2026 | Mar 20 | Apr 10 | $0.40 | |
| Dec 19, 2025 | Dec 19 | Jan 9 | $0.40 | |
| Sep 29, 2025 | Sep 29 | Oct 10 | $0.40 | |
| Jun 20, 2025 | Jun 20 | Jul 11 | $0.40 | |
| Mar 21, 2025 | Mar 21 | Apr 11 | $0.40 | |
| Dec 20, 2024 | Dec 20 | Jan 8 | $0.40 | |
| Sep 20, 2024 | Sep 20 | Oct 9 | $0.40 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 255.30M · Float 254.58M · 99.7% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Dodge & Cox | 37.01M | 14.50% | 13F | Aug 13, 2026 |
| Freemont Capital Pte Ltd | 25.36M | 9.93% | 13F | Aug 13, 2026 |
| Winder Pte. Ltd. | 25.36M | 9.90% | 13G | Feb 14, 2025 |
| BlackRock, Inc. | 23.18M | 9.08% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 16.26M | 6.37% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | de Mendonca Ana Paula Teles | officer: President, Scent | −5,718 | $83.19 |
| Aug 7, 2026 | Marc Birenkrant | officer: Controller & CAO | −1,000 | $85.00 |
| Aug 6, 2026 | Michael DeVeau | officer: EVP, CFO | −8,825 | $85.55 |
| Jun 1, 2026 | Paul J. Fribourg | director | +273,500 | $74.29 |
| Mar 24, 2023 | Mark J. Costa | director | +10 | $84.27 |
Peers
- Archer Daniels Midland
Large-scale food ingredients, flavors, proteins, and sweeteners overlap
- Sensient Technologies
Mid-sized flavors, extracts, colors, and specialty ingredients peer
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| International Flavors & Fragrances | $83.37 | −5.20% | $22.45B | 81.4 | 25.8 | 2.3 | −29.3% |
| Archer Daniels Midland | $81.68 | +0.17% | $39.30B | 22.3 | 14.1 | 0.5 | +7.1% |
| Sensient Technologies | $135.12 | 0.00% | $5.75B | 36.4 | 30.4 | 3.4 | +11.6% |
| Median | 29.4 | 22.3 | 1.9 | +9.3% |